These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32951036)

  • 1. Addressing health disparities in the Food and Drug Administration's artificial intelligence and machine learning regulatory framework.
    Ferryman K
    J Am Med Inform Assoc; 2020 Dec; 27(12):2016-2019. PubMed ID: 32951036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifecycle Regulation of Artificial Intelligence- and Machine Learning-Based Software Devices in Medicine.
    Hwang TJ; Kesselheim AS; Vokinger KN
    JAMA; 2019 Dec; 322(23):2285-2286. PubMed ID: 31755907
    [No Abstract]   [Full Text] [Related]  

  • 3. Policy Implications of Artificial Intelligence and Machine Learning in Diabetes Management.
    Broome DT; Hilton CB; Mehta N
    Curr Diab Rep; 2020 Feb; 20(2):5. PubMed ID: 32008107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study.
    Smith JA; Abhari RE; Hussain Z; Heneghan C; Collins GS; Carr AJ
    BMJ Open; 2020 Oct; 10(10):e039969. PubMed ID: 33055121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
    Zhu S; Gilbert M; Chetty I; Siddiqui F
    Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis.
    Muehlematter UJ; Daniore P; Vokinger KN
    Lancet Digit Health; 2021 Mar; 3(3):e195-e203. PubMed ID: 33478929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulatory environment for artificial intelligence-enabled devices in the United States.
    Liang NL; Chung TK; Vorp DA
    Semin Vasc Surg; 2023 Sep; 36(3):435-439. PubMed ID: 37863617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening the use of artificial intelligence within healthcare delivery organizations: balancing regulatory compliance and patient safety.
    Sendak MP; Liu VX; Beecy A; Vidal DE; Shaw K; Lifson MA; Tobey D; Valladares A; Loufek B; Mogri M; Balu S
    J Am Med Inform Assoc; 2024 Jun; 31(7):1622-1627. PubMed ID: 38767890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continual learning in medical devices: FDA's action plan and beyond.
    Vokinger KN; Feuerriegel S; Kesselheim AS
    Lancet Digit Health; 2021 Jun; 3(6):e337-e338. PubMed ID: 33933404
    [No Abstract]   [Full Text] [Related]  

  • 10. Algorithm Change Protocols in the Regulation of Adaptive Machine Learning-Based Medical Devices.
    Gilbert S; Fenech M; Hirsch M; Upadhyay S; Biasiucci A; Starlinger J
    J Med Internet Res; 2021 Oct; 23(10):e30545. PubMed ID: 34697010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA Review of Radiologic AI Algorithms: Process and Challenges.
    Zhang K; Khosravi B; Vahdati S; Erickson BJ
    Radiology; 2024 Jan; 310(1):e230242. PubMed ID: 38165243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory oversight, causal inference, and safe and effective health care machine learning.
    Stern AD; Price WN
    Biostatistics; 2020 Apr; 21(2):363-367. PubMed ID: 31742358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congress Must Update FDA Regulations for Medical AI.
    Gottlieb S
    JAMA Health Forum; 2024 Jul; 5(7):e242691. PubMed ID: 38990560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review.
    Clark P; Kim J; Aphinyanaphongs Y
    JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilemma over AI and drug patenting already under debate.
    King RD; Courtney P
    Nature; 2018 Aug; 560(7718):307. PubMed ID: 30108355
    [No Abstract]   [Full Text] [Related]  

  • 16. Mature artificial intelligence- and machine learning-enabled medical tools impacting vascular surgical care: A scoping review of late-stage, US Food and Drug Administration-approved or cleared technologies relevant to vascular surgeons.
    Stonko DP; Hicks CW
    Semin Vasc Surg; 2023 Sep; 36(3):460-470. PubMed ID: 37863621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Medical Devices Have a Mind of Their Own: The Challenges of Regulating Artificial Intelligence.
    Boubker J
    Am J Law Med; 2021 Dec; 47(4):427-454. PubMed ID: 35297753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA-approved machine learning algorithms in neuroradiology: A systematic review of the current evidence for approval.
    Yearley AG; Goedmakers CMW; Panahi A; Doucette J; Rana A; Ranganathan K; Smith TR
    Artif Intell Med; 2023 Sep; 143():102607. PubMed ID: 37673576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concepts in U.S. Food and Drug Administration Regulation of Artificial Intelligence for Medical Imaging.
    Kohli A; Mahajan V; Seals K; Kohli A; Jha S
    AJR Am J Roentgenol; 2019 Oct; 213(4):886-888. PubMed ID: 31166758
    [No Abstract]   [Full Text] [Related]  

  • 20. Applications of artificial intelligence in drug development using real-world data.
    Chen Z; Liu X; Hogan W; Shenkman E; Bian J
    Drug Discov Today; 2021 May; 26(5):1256-1264. PubMed ID: 33358699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.